Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

VEGF Has Both Direct and Indirect Neuroprotective Effects in Ischemic Retina

E. Ng; K. Nishijima; G.S. Robinson; A.P. Adamis; D.T. Shima

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4829. doi:

ARVO Annual Meeting Abstract May 2006

A Functional Heparin–Binding Domain is Required for Vegf164–Induced Retinal Leukostasis

K. Nishijima; D. Krilleke; G.S. Robinson; A.P. Adamis; Y.–S. Ng; D.T. Shima

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5502. doi:

ARVO Annual Meeting Abstract May 2006

Cost–Effectiveness of Macugen® versus No Treatment in Age–Related Macular Degeneration Patients

J.C. Javitt; S.R. Earnshaw; C.N. Graham; A.J. Brogan; G.P. Zlateva; A. Pleil; S.N. Shah; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1135. doi:

ARVO Annual Meeting Abstract May 2005

Medical Treatment of Diabetic Macular Edema With Rofecoxib

J.B. Christoforidis; A.P. Adamis; D.J. D'Amico

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):391. doi:

ARVO Annual Meeting Abstract May 2005

Inhibition of Diabetic Leukostasis and Blood–Retinal Barrier Breakdown With a Soluble Form of a Receptor for Advanced Glycation End Products

Y. Kaji; T. Usui; S. Ishida; K. Yamashiro; S. Amano; T. Oshika; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):404. doi:

ARVO Annual Meeting Abstract May 2005

Mural Cell Loss Following Inhibition of PDGF Signaling Enhances the Effect of Anti–VEGF Therapy on Corneal Neovascularization

N. Jo; C. Mailhos; K. Nishijima; M. Ju; E. Cheung; G.S. Robinson; A.P. Adamis; D.T. Shima

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):468. doi:

ARVO Annual Meeting Abstract May 2005

VEGF164 Governs Leukocyte Dynamics and Pathological Neovascularization

K. Nishijima; N. Jo; Y.–S. Ng; G.S. Robinson; P.A. D'amore; D.T. Shima; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1372. doi:

ARVO Annual Meeting Abstract May 2004

VEGF164 is required for ischemia–induced retinal neovascularization in mice

K. Nishijima; N. Jo; Y.–S. Ng; M. Gee; P.A. D’Amore; D.T. Shima; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):468. doi:

ARVO Annual Meeting Abstract May 2004

Quantitative Measurements of Ganglion Cell Loss in a Glaucoma Mouse Model

L. Zhong; S.J. Samuelsson; S. Poor; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):874. doi:

ARVO Annual Meeting Abstract May 2004

VEGF RNA Aptamer Binding Specificity and Inhibition of Ligand binding to VEGF Receptors in vitro

E. Ng; D. Krilleke; A. De Erkenez; L. Mullin; G. Robinson; A.P. Adamis; D.T. Shima

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1794. doi:

ARVO Annual Meeting Abstract May 2004

Inhibitory Effect of an Antibody to Cryptic Collagen Type IV Epitopes on Choroidal Neovascularization

N. Jo; C. Mailhos; K. Nishijima; A. Snodgrass; B. Freimark; A.P. Adamis; D.T. Shima

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1855. doi:

ARVO Annual Meeting Abstract May 2004

VEGF–mediated neuroprotection in ischemic retina

D.T. Shima; K. Nishijima; N. Jo; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3270. doi:

ARVO Annual Meeting Abstract May 2003

VEGF Dependent Leukocyte Infiltration and Blood-Retinal Barrier Breakdown in Endotoxin-Induced Uveitis

K. Yamashiro; S. Ishida; T. Usui; Y. Kaji; Y. Ogura; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):719. doi:

ARVO Annual Meeting Abstract May 2003

Long-term Leukocyte-mediated Vascular Pathology in the Diabetic Retina

A.M. Joussen; V. Poulaki; M.L. Le; K. Koizumi; C. Esser; H. Janicki; S. Fauser; T.S. Kern; B. Kirchhof; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3291. doi:

ARVO Annual Meeting Abstract May 2003

Non-Invasive Tonometry in the Mouse

E. Ahmed; J. Ma; I. Rigas; N. Hafezi-Moghadam; E. Iliaki; E.S. Gragoudas; J.W. Miller; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3336. doi:

ARVO Annual Meeting Abstract May 2003

VEGF164 is Pro-Inflammatory in the Diabetic Retina

S. Ishida; T. Usui; K. Yamashiro; Y. Kaji; E. Ahmed; K.G. Carrasquillo; S. Amano; T. Hida; Y. Oguchi; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3895. doi:

ARVO Annual Meeting Abstract May 2003

In Vivo Transscleral Delivery of FITC-Conjugated Molecules to the Rabbit Choroid and Retina

I.K. Rigas; P. Calias; K.G. Karrasquillo; E.S. Gragoudas; J.W. Miller; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4432. doi:

ARVO Annual Meeting Abstract May 2003

Transscleral Delivery of an Anti-VEGF Aptamer in a Rabbit Model

K.G. Carrasquillo; S. Ray; I.K. Rigas; P. Calias; J.W. Miller; E.S. Gragoudas; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4442. doi:

ARVO Annual Meeting Abstract May 2003

Encapsulation of Anti-ICAM-1 Antibodies into PLA-PEG Microspheres: In vitro and in vivo Characterization

S.K. Ray; K.G. Carrasquillo; I. Rigas; P. Calias; J.W. Miller; E.S. Gragoudas; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4450. doi:

ARVO Annual Meeting Abstract May 2003

Advanced Glycation End Products Induce Apoptosis in Corneal Endothelium

Y. Kaji; S. Amano; T. Oshika; T. Usui; K. Yamashiro; S. Ishida; T. McMullen; J. Moore; A.P. Adamis; S. Horiuchi

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4715. doi:

1 2

Next 20 Results »

Advertisement